Pancreatic Cancer: Articles of Note @PharmaceuticalIntelligence.com
Curator: Aviva Lev-Ari, PhD, RN
Li -Fraumeni Syndrome and Pancreatic Cancer
Author: Marzan Khan, B.Sc.
https://pharmaceuticalintelligence.com/2016/12/14/li-fraumeni-syndrome-and-pancreatic-cancer/
Pancreatic cancer tumorigenesis is neither gradual nor follows the accepted mutation order – A Study of changes in DNA copy number and their associated rearrangements in tumour-enriched genomes: Mitotic errors, consistent with punctuated equilibrium as the principal evolutionary trajectory.
Reporter: Aviva Lev-Ari, PhD, RN
DISCUSSION – Genomics-driven personalized medicine for Pancreatic Cancer
Reporter: Aviva Lev-Ari, PhD, RN
COMBAT study: Combination of BL-8040 and KEYTRUDA® (pembrolizumab) for Pancreatic Cancer: Collaboration Agreement Merck, BioLineRx and MD Anderson Cancer Center
Reporter: Aviva Lev-Ari, PhD, RN
A New Potential Target for Pancreatic Cancer Treatment: Rapid Screening Technique finds Gene Defending Tumors from DNA Damage @M. D. Anderson Cancer Center
Reporter: Aviva Lev-Ari, PhD, RN
Oncolytic Virotherapy for Pancreatic Cancer: Overcoming Obstacles in Oncolytic Virus Delivery
Reporter: Aviva Lev-Ari, PhD, RN
Trovagene’s ctDNA Liquid Biopsy urine and blood tests to be used in Monitoring and Early Detection of Pancreatic Cancer
Reporters: David Orchard-Webb, PhD and Aviva Lev-Ari, PhD, RN
Hyaluronidase treatment of high HA pancreatic cancer increased progression-free survival
Author: David Orchard-Webb, PhD
Targeting paclitaxel to the pancreas with a biodegradable drug-eluting device
Author: David Orchard-Webb, PhD
Recent Research On SMAD4 In Pancreatic Cancer
Curator: David Orchard-Webb, PhD
https://pharmaceuticalintelligence.com/2016/06/27/recent-research-on-smad4-in-pancreatic-cancer/
Pancreatic Cancer Modeling using Retrograde Viral Vector Delivery and IN-Vivo CRISPR/Cas9-mediated Somatic Genome Editing
Curators: Larry H. Benstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Mutations in RAS genes
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/04/23/mutations-in-ras-genes/
TP53 tumor Drug Resistance Gene Target
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/12/27/p53-tumor-drug-resistance-mechanism-target/
Pancreatic Cancer Targeted Treatment?
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2016/05/18/pancreatic-cancer-targeted-treatment/
Aduro Biotech Phase II Pancreatic Cancer Trial CRS-207 plus cancer vaccine GVAX Fails
Reporter: Stephen J Williams, PhD
The “Guardian Of The Genome” p53 In Pancreatic Cancer
Curator: David Orchard-Webb, PhD
Targeting Epithelial To Mesenchymal Transition (EMT) As A Therapy Strategy For Pancreatic Cancer
Curator: David Orchard-Webb, PhD
Pancreatic Cancer at the Crossroads of Metabolism
Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/10/13/pancreatic-cancer-at-the-crosroad-of-metabolism/
Using CRISPR to investigate pancreatic cancer
Reporter: Aviva Lev-Ari, PhD, RN
https://pharmaceuticalintelligence.com/2015/07/31/using-crispr-to-investigate-pancreatic-cancer/
Prostate Cancer Cells: Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition
Reporter-Curator: Stephen J. Williams, PhD
@Mayo Clinic: Inhibiting the gene, protein kinase D1 (PKD1), and its protein could stop spread of this form of Pancreatic Cancer
Reporter: Aviva Lev-Ari, PhD, RN
Locally Advanced Pancreatic Cancer: Efficacy of FOLFIRINOX
Reporter: Aviva Lev-Ari, PhD, RN
Consortium of European Research Institutions and Private Partners will develop a microfluidics-based lab-on-a-chip device to identify Pancreatic Cancer Circulating Tumor Cells (CTC) in blood
Reporter: Aviva Lev-Ari, PhD, RN
What`s new in pancreatic cancer research and treatment?
Reporter: Aviva Lev-Ari, PhD, RN
Pancreatic Cancer: Genetics, Genomics and Immunotherapy
Author: Tilda Barliya, PhD
https://pharmaceuticalintelligence.com/2013/04/11/update-on-pancreatic-cancer/
Targeting the Wnt Pathway
Writer and Curator: Larry H Bernstein, MD, FCAP
https://pharmaceuticalintelligence.com/2015/04/10/targeting-the-wnt-pathway-7-11/
Gene Amplification and Activation of the Hedgehog Pathway
Curator: Larry H Bernstein, MD, FCAP
Leave a Reply